NVCR — NovoCure Ltd
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in NovoCure Ltd (NVCR), worth $37.16M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $29.57M | 0.04% | +25.8% |
| Essex | $6.66M | 0.87% | -2.8% |
| VanEck | $733.40K | 0.00% | +91.8% |
| IMC | $194.42K | 0.00% | -58.2% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.